159 related articles for article (PubMed ID: 7542033)
1. Prostate cancer screening (United States).
Waterbor JW; Bueschen AJ
Cancer Causes Control; 1995 May; 6(3):267-74. PubMed ID: 7542033
[TBL] [Abstract][Full Text] [Related]
2. The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program.
Smart CR
Cancer; 1997 Nov; 80(9):1835-44. PubMed ID: 9351557
[TBL] [Abstract][Full Text] [Related]
3. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths.
Neppl-Huber C; Zappa M; Coebergh JW; Rapiti E; Rachtan J; Holleczek B; Rosso S; Aareleid T; Brenner H; Gondos A;
Ann Oncol; 2012 May; 23(5):1325-1334. PubMed ID: 21965474
[TBL] [Abstract][Full Text] [Related]
4. The role of increasing detection in the rising incidence of prostate cancer.
Potosky AL; Miller BA; Albertsen PC; Kramer BS
JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
[TBL] [Abstract][Full Text] [Related]
5. Interpreting recent trends in prostate cancer incidence and mortality.
Gann PH
Epidemiology; 1997 Mar; 8(2):117-20. PubMed ID: 9229198
[No Abstract] [Full Text] [Related]
6. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
Etzioni R; Penson DF; Legler JM; di Tommaso D; Boer R; Gann PH; Feuer EJ
J Natl Cancer Inst; 2002 Jul; 94(13):981-90. PubMed ID: 12096083
[TBL] [Abstract][Full Text] [Related]
7. Impact of screening on incidence and mortality of prostate cancer in the United States.
Potosky AL; Feuer EJ; Levin DL
Epidemiol Rev; 2001; 23(1):181-6. PubMed ID: 11588846
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen: the new early detection test for prostate cancer.
Greco KE; Blank B
Nurse Pract; 1993 May; 18(5):30-8. PubMed ID: 7689192
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer screening in Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
[TBL] [Abstract][Full Text] [Related]
10. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.
Brawley OW
Cancer; 1997 Nov; 80(9):1857-63. PubMed ID: 9351560
[TBL] [Abstract][Full Text] [Related]
11. Early-stage prostate cancer, PSA screening rates decline.
Printz C
Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
[No Abstract] [Full Text] [Related]
12. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
[TBL] [Abstract][Full Text] [Related]
13. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
[TBL] [Abstract][Full Text] [Related]
14. Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013.
Houston KA; King J; Li J; Jemal A
J Urol; 2018 Mar; 199(3):676-682. PubMed ID: 28965781
[TBL] [Abstract][Full Text] [Related]
15. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma of the prostate: overview of the most common malignancy in men.
Carson CC
N C Med J; 2006; 67(2):122-7. PubMed ID: 16752715
[No Abstract] [Full Text] [Related]
17. Prostate cancer in Czech Republic 1959-1992. Descriptive survey.
Celko AM
Cent Eur J Public Health; 1995 Aug; 3(3):119-23. PubMed ID: 8535365
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer screening. Why the controversy?
Walther PJ
Surg Oncol Clin N Am; 1995 Apr; 4(2):315-34. PubMed ID: 7540938
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Devesa SS; Aalen OO
Eur J Epidemiol; 2017 Jun; 32(6):511-520. PubMed ID: 27431530
[TBL] [Abstract][Full Text] [Related]
20. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
